22 Jun, 2023 New York State’s End to Non-Compete Agreements By Lori Goodman Nicole Foster Sonia Bennett New York may be the next state to jump on the non-compete “ban” wagon. On June 20, 2023, the New York State Assembly approved bill...
22 Jun, 2023 SEC’s Cybersecurity Disclosure Rules Delayed Until October 2023 By Beth George Megan Kayo Brock Dahl Timothy Howard +1 more... Show less On June 13, 2023, the Securities and Exchange Commission released the Spring 2023 Regulatory Agenda, which delayed the anticipated date...
16 Jun, 2023 The Fair Use Defense for Generative AI Tools After Warhol V. Goldsmith By Menachem Kaplan Marissa Yu Luc Von Danwitz For months, both the artist and IP legal communities eagerly awaited the US Supreme Court’s decision in the case of Andy Warhol...
13 Jun, 2023 Takeaways Report from 9th Annual Spring Forum on M&A and the Boardroom By Ethan Klingsberg Thank you to the over 1,000 participants (including over 300 in person) at the 9th Annual Spring Forum on M&A and Boardroom, co-hosted by...
07 Jun, 2023 Return of the CVR By Adam Golden Mark Appleton The recent surge in bolt-on M&A in the life sciences sector is being fueled by the use of contingent value rights. Notwithstanding...
06 Jun, 2023 SEC Issues Three C&DIs Addressing the Rule 10b5-1 Amendments By Pamela Marcogliese Elizabeth Bieber Jeremy Barr Taryn Zucker Zo Khalid Jennifer Burrow +3 more... Show less On May 25, 2023, the staff of the SEC’s Division of Corporate Finance (the “Staff”) released three new compliance and disclosure...
30 May, 2023 Looking Beyond the Privacy Policy: Regulatory Scrutiny of Dark Patterns in User Interfaces By Christine Lyon Christine Chong This article was originally published in the May 2023 edition of the CPI TechREG Chronicles. WHAT IS MEANT BY “DARK PATTERNS” IN THE...
30 May, 2023 Key Takeaways from the 21st Annual Biomed Israel Conference By Ben Cohen The 21st annual Biomed Israel Conference, attended by thousands of industry leaders from 45 countries, presented a juxtaposition of...
24 May, 2023 Ongoing Initiatives at the USPTO and FDA and Their Potential Impact on the Life Sciences Industry in the United States By Kristen Riemenschneider Jeff Jay Jake Silvers In the past few months, proposals from the United States Patent and Trademark Office (“USPTO”) have drawn the attention of organizations,...
23 May, 2023 FTC v. Amgen/Horizon: FTC’s Pursuit of a Novel Theory Signals Greater Scrutiny on the Horizon for Pharmaceutical Mergers By Laura Onken Meredith Mommers Katie Kissinger On May 16, 2023, the Federal Trade Commission sued to block Amgen Inc.’s purchase of Horizon Therapeutics plc, showing that the agency...
23 May, 2023 2023 ACC Life Sciences Conference: Structuring Considerations for Biotechs By Jeff Jay Jake Silvers The Association of Corporate Counsel hosted its annual Life Sciences Conference from May 9-11, 2023, which featured presentations from a...
23 May, 2023 New York Attorney General Proposes Novel Crypto Legislation By Timothy Howard Brock Dahl Scott Eisman Andrew Bulovsky Adam Silow +2 more... Show less Earlier this month, New York Attorney General Letitia James proposed the Crypto, Protection, Transparency, and Oversight Act (CRPTO Act)...